Telix Pharmaceuticals, 2.375% 30jul2029, AUD (Conv.) (FIGI RegS BBG01NYC0C89, XS2862961492, WKN A3L173)
国際債券, 転換社債, Senior Unsecured
国際債券, 転換社債, Senior Unsecured
|
Telix Pharmaceuticals Limited operates as a biotechnology company. The Company develops and commercializes molecularly-targeted radiation therapy for the treatment of prostate, renal, and brain cancer. Telix Pharmaceuticals serves patients worldwide.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡